Cel-Sci Corporation
Vienna, VA, US· latest recorded location
Cel-Sci Corporation is named on 16 US grants and 12 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 16
- Published applications
- 12
- Inventors
- 13
- Granted in 2026 so far
- 0
- Most recent grant
- 22 Jun 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 2 | 1 |
| 2006 | 1 | 2 |
| 2007 | 2 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 3 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
By publication year.
Technology areas
Share of 28 documents
- A61KMedicines and medical preparations28
- C07KPeptides20
- C12NMicroorganisms or enzymes15
- A61PTherapeutic uses of medicines13
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests8
- Y02ATechnologies for adaptation to climate change5
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
Recent patents
- Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis22 Jun 2021US 11,041,013 B2
- Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof26 Mar 2019US 10,238,747 B2
- Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions15 Jan 2019US 10,179,164 B2
- Method for inducing an immune response and formulations thereof15 Jan 2019US 10,179,174 B2
- Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions14 Aug 2007US 7,256,254 B2
- Novel peptides for vaccination and treatment of 2019-ncov infections2 Sep 2021US 2021/0268101 A1
- Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis9 Jun 2016US 2016/0158330 A1
- Method for inducing an immune response and formulations thereof21 May 2015US 2015/0140065 A1
- Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions25 Sep 2014US 2014/0286858 A1
- Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof10 Oct 2013US 2013/0266599 A1
Most cited
By later US patents
- Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same21US 5,652,342 A1997
- Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same13US 6,096,315 A2000
- Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture10US 6,896,879 B22005
- Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions10US 6,995,237 B12006
- Modified HGP-30 peptides, conjugates, compositions and methods of use7US 6,093,400 A2000